Evidence map›Paper›PMID 29844110›Full record

ArticlemBio2018

Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir".

Isabelle Malet, Frédéric Subra, Clémence Richetta, Charlotte Charpentier, Gilles Collin, Diane Descamps, Vincent Calvez, Anne-Geneviève Marcelin, Olivier Delelis

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Isabelle MaletSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France.
Frédéric SubraLBPA, ENS Cachan, CNRS UMR 8113, IDA FR3242, Université Paris-Saclay, Cachan, France.
Clémence RichettaLBPA, ENS Cachan, CNRS UMR 8113, IDA FR3242, Université Paris-Saclay, Cachan, France.
Charlotte CharpentierIAME, UMR1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Hôpital Bichat, Laboratoire de Virologie, Paris, France.
Gilles CollinIAME, UMR1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Hôpital Bichat, Laboratoire de Virologie, Paris, France.
Diane DescampsIAME, UMR1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Hôpital Bichat, Laboratoire de Virologie, Paris, France.
Vincent CalvezSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France.
Anne-Geneviève MarcelinSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France.
Olivier DelelisLBPA, ENS Cachan, CNRS UMR 8113, IDA FR3242, Université Paris-Saclay, Cachan, France delelis@lbpa.ens-cachan.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heterocyclic Compounds, 3-RingHIV-1DolutegravirDrug Resistance, ViralHIV InfectionsHIV Integrase InhibitorsIntegrase InhibitorsOxazinesPiperazinesPyridonesRNADolutegravirHeterocyclic Compounds, 3-RingHIV Integrase InhibitorsIntegrase InhibitorsOxazinesPiperazinesPyridonesRNA1-LTR3' PPTdolutegravirHIV-1integration

Identifiers

PMID29844110
PMCPMC5974467

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.